Document is current
Any future updates will be listed below
-
Authors
Santosa, Ailiana https://orcid.org/0000-0002-1848-2867
Collin, Julius
Dahlén, Elin
Lignell, Anders
Furberg, Maria https://orcid.org/0000-0002-7580-6485
Ternhag, Anders https://orcid.org/0000-0003-4968-8945
Ljung, Rickard https://orcid.org/0000-0002-0654-4530
Nyberg, Fredrik https://orcid.org/0000-0003-0892-5668
-
Funding
Funding for this research was provided by:
Forskningsrådet om Hälsa, Arbetsliv och Välfärd (2024-01711)
Svenska Forskningsrådet Formas (2020-02828)
- License Information
-
More Information
Article History
Received: 9 February 2025
Accepted: 16 March 2026
First Online: 1 April 2026
Competing interests
: The authors report the following financial and non-financial interests that could be perceived as competing interests: F.N. owns shares in AstraZeneca. A.S. and F.N. participate in research projects funded by Bayer and AstraZeneca (regulator-mandated phase IV study; investigator-initiated study), with funding paid to their employer (no personal remuneration) and unrelated to the present work. A.L., M.F. and R.L. are employees of the Swedish Medical Products Agency, and J.C. and A.T. are employees of the Public Health Agency of Sweden. E.D. was employed at the Swedish Medical Products Agency at the time the study was conducted but has since changed employment. The views expressed in this article do not necessarily reflect those of their respective agencies.
